GLENFID PHARMA PVT LTD is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
1983
Year Founded
$5.4 Billion
Global Revenue
4th Largest
Generic Pharmaceutical
Company Worldwide
41000+
Employees
Across The Globe
About GLENFID PHARMA PVT LTD.
Our Code of Conduct
Our Global Code of Conduct governs every aspect of our operations. Glenfid Pharma is a team of thousands of people, working across many countries, speaking multiple languages, and all united, with one vision: Reaching People & Touching Lives Globally as a Leading Provider of Valued Medicines. Through active fieldwork, dedicated research teams, and in recognition of the efforts who work behind the scenes to combat illness and disease, the Sun Pharmaceutical Group helps as many people as possible, to secure their right to good health. The way we work every day is important to us.
Our Values & Vision
Reaching People And Touching Lives Globally As A Leading Provider Of Valued Medicines. Our values represent our promise to our stakeholders.
- Quality :- Get it right the first time.
- Reliability :- Maintain efficiency & discipline in all processes & systems and fulfil the promises made to stakeholders.
- Trust :- Be transparent in dealings.
- Consistency :- Endeavour to bring new products to the market & consistently deliver value to stakeholders.
- Innovation :- Implement new ideas & technologies to meet unmet needs and think ahead of times.
Sunology
Sunology, a combination of Sun and Ideology is the way of life at Glenfid Pharma.
Humility
- Under promise and over deliver
- Let your work speak for you
- Always put ‘we’ before ‘me’
- Learn from mistakes
Passion
- Infuse energy in everything that you do
- Walk that extra mile
- Inspire others
- Do your best in every situation
Integrity
- Do the right thing with conviction and without fear
- Practice honesty, impartiality and fairness at all times
- Adhere to strong ethical and moral standards
- Have courage to call out what is not right
Innovation
- Strive to implement new ideas & technologies to meet unmet needs
- Encourage others to think out-of-the-box
- Do not limit yourself
- Believe in raising the bar every time
Diversified Specialty and Generics Portfolio
We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Our broad portfolio of more than 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
Every year, we sell over 30 billion doses covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology and respiratory among others.
Driven by Innovation
The first among Indian pharmaceutical companies to realise and embrace the importance of investing in research, we invest up to 6-8% of our global revenues into Research and Development (R&D) every year.
Our core strength lies in our ability to excel in developing generics and technologically complex products backed by our dedicated teams in formulations, process chemistry, and analytical development.
Our capabilities extend beyond the development of differentiated products, including liposomal products, inhalers, lyophilized injections, nasal sprays, and controlled release dosage forms.
Our R&D team comprises over 2,800 people.
Press Release
From humble beginnings in 1983, Glenfid Pharma has grown to become one of the largest generic pharmaceutical companies worldwide. We are the largest pharmaceutical company in India.
In the US, we are among the leading generic pharmaceutical companies and are ranked second by prescriptions in the generic dermatology market.
We are the largest Indian company in emerging markets with a presence in over 80 markets. Brazil, Mexico, Russia, Romania and South Africa are some of our key emerging markets.
We are present across all major markets in Western Europe, Canada, Australia, New Zealand, Japan and China among others.
Our presence in emerging markets and the developing world enables our teams to cross-sell and build brands with ease.
